Peride Ileana, Tiglis Mirela, Neagu Tiberiu Paul, Niculae Andrei, Checherita Ionel Alexandru
Clinical Department No. 3, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Clinical Department No. 14, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Diagnostics (Basel). 2022 Apr 1;12(4):880. doi: 10.3390/diagnostics12040880.
Chronic kidney disease (CKD) is associated with different complications, including chronic kidney disease-mineral and bone disorder (CKD-MBD), which represents a systemic disorder that involves the presence of different mineral or bone structure abnormalities (i.e., modification of bone turnover, strength, volume, etc.), including even vascular calcification development. Even if, over the years, different pathophysiological theories have been developed to explain the onset and progression of CKD-MBD, the influence and importance of serum magnesium level on the evolution of CKD have only recently been highlighted. So far, data are inconclusive and conflicting; therefore, further studies are necessary to validate these findings, which could be useful in developing a better, more adequate, and personalized management of CKD patients.
慢性肾脏病(CKD)与多种并发症相关,包括慢性肾脏病 - 矿物质和骨异常(CKD - MBD),这是一种全身性疾病,涉及不同矿物质或骨结构异常(如骨转换、强度、体积等改变),甚至包括血管钙化的发展。尽管多年来已经提出了不同的病理生理理论来解释CKD - MBD的发生和发展,但血清镁水平对CKD进展的影响和重要性直到最近才受到关注。到目前为止,数据尚无定论且相互矛盾;因此,需要进一步研究来验证这些发现,这可能有助于为CKD患者制定更好、更合适和个性化的治疗方案。